SAP SE (SAP)
$217.85+1.43%Close
BUYBULL · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV19.0%–89.1%
- Market cap
- $253.8B
- Beta
- 0.78
- Div yield
- 1.40%
- P/E (TTM)
- 27.53
- IV-%ile
- 90
- IV ATM
- 56.4%
- Short % float
- 0.40%
- Days to cover
- 2.4
- SI change
- -19.1%
- 1W
- +4.87%
- 1M
- +5.57%
- vs SPY 1W
- +4.44%
- vs SPY 1M
- +3.51%
Industry peers
FMP comparable companies · ranked by market cap
- MSFTBUYMicrosoft Corporation$3.9TBULLQ 24$529.30+1.33%
- ORCLSELLOracle Corporation$417.0BBEARQ 20$144.76-2.84%
- IBMSELLInternational Business Machines Corporation$208.5BRECOVERYQ 15$221.29-0.05%
- CRMSELLSalesforce, Inc.$184.3BBEARQ 25$224.99+2.09%
- ACNBUYAccenture plc$118.3BRECOVERYQ 20$193.40+2.78%
- ADPSELLAutomatic Data Processing, Inc.$104.9BBEARQ 18$262.36+0.87%
- WDAYSELLWorkday, Inc.$48.9BBEARQ 15$186.55+0.89%
- CGEMYCapgemini SE$20.9B$24.63
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 65
- VALUE
- 49
- GROWTH
- 56
- GARP
- 38
- TYPE
- Dividend Compounder (blended)
Composite of Value · Growth · GARP
ROIC10.6%
REV YoY-
ROE17.6%
EPS YoY-
ROA10.3%
GROSS73
OP27
NET20
[VALUATION]
P/E TTM27.53
P/E FWD28.41
SECTOR PE48.02
INDUSTRY PE45.61
P/B4.86
P/FCF-
EV/EBITDA16.09
EV/EBIT-
PEG2.25
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.15
ND/EBITDA-
BETA0.78
Company news
FAQ
- What is LOPJLB’s current signal on SAP?
- LOPJLB’s latest quantitative signal on SAP SE (SAP) is BUY in a BULL regime. Signals are updated daily.
- What market regime is SAP in?
- SAP SE (SAP) is currently classified in the BULL HMM market regime on LOPJLB.
- What does SAP SE (SAP) do?
- SAP SE, founded in Walldorf, Germany, in 1972, is a global provider of diverse software applications, technology, and services. The company's core enterprise resource planning (ERP) platform, SAP S/4HANA, offers robust functionalities for finance, risk management, project execution, procurement, manufacturing, supply chain optimization, asset management, and research and development. For human …